Graft-versus-host disease and graft-versus-leukemia effect in mice grafted with peripheral newborn blood

Blood

Volumn 92, Issue 10, 1998, Pages 3968-3975

  De la Selle, Véronique ^b   Gluckman, Eliane ^b   Bruley Rosset, Martine ^a  

^a INSERM   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; MESSENGER RNA; PHYTOHEMAGGLUTININ;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD TRANSFUSION; CANCER IMMUNOTHERAPY; CELL MATURATION; DNA SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HELPER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; UMBILICAL CORD BLOOD;

EID: 0032533910     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.10.3968     Document Type: Article

References (35)

1. Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, Arcese W, Pasquini R, Ortega J, Souillet G, Ferreira E, Laporte JP, Fernandez M, Chastang C: Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med 337:373, 1997
2. Wagner JE, Kernan NA, Steinbuch M, Broxmeyer HA, Gluckman E: Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet 346:214, 1995
3. Kurtzberg J, Laughlin M, Graham ML, Smith C, Olson JF, Halperin EC, Ciocci G, Carrier C, Stevens CE, Rubinstein P: Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 335:157, 1996
4. +unprimed T cells. J Immunol 152:5613, 1994
5. Keever CA, Abu-Hajir M, Graf W, McFadden P, Prichard P, O'Brien J, Flomenberg N: Characterization of the alloreactivity and anti-leukemia reactivity of cord blood mononuclear cells. Bone Marrow Transplant 15:407, 1995
6. Harris DT, Schumacher MJ, LoCascio J, Booth A, Bard J, Boyse EA: Immunoreactivity of umbilical cord blood and post-partum maternal peripheral blood with regard to HLA-haploidentieal transplantation. Bone Marrow Transplant 14:63, 1994
7. Harris DT, Schumacher MJ, LoCascio J, Besencon FJ, Olson GB, Deluca D, Shenker L, Bard J, Boyse EA: Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc Natl Acad Sci USA 89:10006, 1992
8. Gerli R, Bertotto A, Crupi S, Arcangeli C, Marinelli I, Spinozzi F, Spinozzi C, Cernetti C, Angelella P, Rambotti P: Activation of cord T lymphocytes. I. Evidence for a defective T cell mitogenesis induced through the CD2 molecule. J Immunol 142:2583, 1989
9. Madrigal JA, Cohen SB, Gluckman E, Charron DJ: Does cord blood transplantation result in lower graft-versus-host disease? It takes more than two to tango. Hum Immunol 56:1, 1997
10. Barret AJ: Mechanisms of the graft-versus-leukemia reaction. Stem Cells 15:248, 1997
11. Harris DT: In vitro and in vivo assessment of the graft-versusleukemia activity of cord blood. Bone Marrow Transplant 15:17, 1995
12. Harris DT, LoCascio J, Besencon FJ: Analysis of the alloreactive capacity of human umbilical cord blood: implications for graft-versushost disease. Bone Marrow Transplant 14:545, 1994
13. de La Selle V, Gluckman E, Bruley-Rosset M: Newborn blood can engraft adult mice without inducing graft-versus-host disease across non H-2 antigens. Blood 87:3977, 1996
14. + cells. Eur J Immunol 22:329, 1992
15. Adkins B, Ghanei A, Hamilton K: Developmental regulation of IL-4, IL-2, and IFN-γ production by murine peripheral T lymphocytes. J Immunol 151:6617, 199
16. Bonomo A, Kehn PJ, Shevach EM: Premature escape of double-positive thymocytes to the periphery of young mice. Possible role in autoimmunity. J Immunol 152:1509, 1994
17. Coutinho GC, Delassus S, Kourilsky Ph, Bandeira A, Coutinho A: Developmental shift in the patterns of interleukin production in early post-natal life. Eur J Immunol 24:1858, 1994
18. Alard P, Lantz O, Sebagh M, Calvo CF, Weill D, Chavanel G, Senick A, Charpentier B: A versatile ELISA-PCR assay for mRNA quantitation from a few cells. Biotechniques 15:730, 1993
19. de La Selle V, Miconnei I, Gilbert D, Bruley-Rosset M: Peripheral tolerance to host minor histocompatibility antigens in radiation bone marrow chimeras abrogates lethal GVHD while preserving GVL effect. Bone Marrow Transplant 16:111, 1995
20. Johnson BD, Drobyski WR, Truitt RL: Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease. Bone Marrow Transplant 11:329, 1993
21. Giralt S, Hester J, Huh Y, Hirsch-Ginsberg C, Rondon G, Seong D, Lee M, Gajewski J, Van Besien K, Khouri I: CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow tranplantation. Blood 86:4337, 1995
22. Mackinnon S, Papadopoulos EB, Carabasi MH, Reich L, Collins NH, Boulad F, Castro-Malaspina H, Childs BH, Gillio AP, Kernan NA: Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation; separation of graft-versus-leukemia responses from graft-versus-host disease. Blood 86:1261, 1995
23. + T-cell subsets in vivo: Immunol Rev 123:189, 1991
24. - thymocytes. Seminars Immunol 4:187, 1992
25. Broski AP, Halloran PF: Tissue distribution of IL-10 mRNA in normal mice. Transplantation 57:582, 1994
26. Howard M, O'Garra A: Biological properties of interleukin 10. Immunol Today 13:6, 1992
27. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737, 1997
28. Miconnet I, de La Selle V, Tucek C, Huchet R, Bonnardelle D, Bruley Rosset M: Tissue distribution and polymorphism of minor histocompatibility antigens involved in GVHR. Immunogenetics 39:78, 1994
29. De Bueger M, Bakker A, Van Rood JJ, Van der Woude F, Goulmy E: Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigen. J Immunol 149:1788, 1992
30. Sautois B, Fillet G, Beguin Y: Comparative cytokine production by in vitro stimulated mononucleated cells from cord blood and adult blood. Exp Hematol 25:103, 1997
31. Quian JX, Lee SM, Suen Y, Knoppel E, van de Ven C, Cairo MS: Decreased interleukin-15 from activated cord versus adult peripheral blood mononuclear cells and the effect of interleukin-15 in upregulating ami tumor immune activity and cytokine production in cord blood. Blood 90:3106, 1997
32. Lee SM, Suen Y, Chang L, Bruner V, Quian J, Indes J, Knoppel E, van de Ven C, Cairo MS: Decreased interleukin-12 (IL-12) from activated cord versus adult peripheral blood mononuclear cells and upregulation of interferon-gamma, natural killer, and lymphokine-activated killer activity by IL-12 in cord blood mononuclear cells. Blood 88:945, 1996
33. Palacios R, Andersson U: Autologous mixed lymphocyte reaction in human cord blood lymphocytes: decreased generation of helper and cytotoxic T cell functions and increased proliferative responses and induction of suppressor T cells. Cell Immunol 66:88, 1982
34. Flomenberg N, Keever CA: Cord blood transplants: potential utility and potential limitations. Bone Marrow Transplant 10:115, 1992
35. Locatelli F, Comoli P, Giorgiani G, Carra AM, Di Giulio G, DiMaggio EM, Pellegrini N, Maccario R: Infusion of donor-derived peripheral blood leukocytes after transplantation of cord blood progenitor cells can increase the graft-versus-leukemia effect. Leukemia 11:729, 1997